Intermittent fasting can meaningfully improve blood sugar control in people with type 2 diabetes. Across multiple clinical trials, it has reduced HbA1c (the standard measure of long-term blood sugar) by anywhere from 0.4% to nearly 3%, depending on the fasting method and the person’s starting point. That said, it carries real risks if you take certain diabetes medications, and it requires planning with your healthcare team before you start.
How Fasting Affects Blood Sugar
When you fast for extended periods, your body shifts from burning incoming food for energy to tapping stored fat. For someone with type 2 diabetes, this shift has several downstream effects. Fasting cycles appear to stimulate the production of new insulin-producing cells in the pancreas, which can improve how well your body handles glucose over time. The interplay between feeding and fasting also helps reset your body’s internal clock, which plays a role in normalizing blood sugar rhythms.
Clinical studies confirm these effects show up in measurable ways. A network meta-analysis in Frontiers in Nutrition found that all three major fasting approaches significantly improved insulin resistance scores compared to a regular diet. In practical terms, that means the cells in your body become better at responding to insulin, requiring less of it to pull sugar out of your bloodstream.
What the Numbers Look Like
The improvements in blood sugar control are significant enough to rival some medications. In a meta-analysis of four trials covering 280 participants, intermittent fasting produced an average HbA1c reduction of 1.85 percentage points. To put that in perspective, many diabetes drugs aim for a reduction of 0.5% to 1.0%.
The benefits were not evenly distributed. People taking insulin saw the largest improvements, with an average HbA1c drop of 2.8%. Those managed with oral medications saw a smaller but still meaningful reduction of 0.54%. People who started with higher HbA1c levels benefited the most: in one 12-month study, participants who began above 8% saw an average drop of 1.4%, while those who started below 6% saw almost no change. This makes sense, as there’s simply more room for improvement when blood sugar is poorly controlled.
Individual trial results reinforce this pattern. A 12-week trial found a significant HbA1c reduction in the fasting group while the control group stayed flat. A 20-week study testing two days per week of very low calorie intake saw HbA1c drop by 0.7% to 1.2%, depending on how many fasting days participants followed, while the control group saw virtually no change.
Can Fasting Put Diabetes Into Remission?
One of the most striking findings comes from a large real-world study of 1,778 people following an intermittent calorie-restricted diet. About 20% achieved diabetes remission, defined as stopping all glucose-lowering medications for at least three months while maintaining an HbA1c below 6.5%. In the control group eating a standard diet, only 2% hit that same benchmark.
These numbers are encouraging, but context matters. About 60% of the fasting group completed the full intervention and follow-up, meaning a substantial portion dropped out. Remission also doesn’t mean cure. Diabetes UK notes that while short-term evidence for fasting and blood sugar reduction is promising, more research is needed to confirm whether these remission results hold up over years.
Comparing Fasting Methods
The three most studied approaches for type 2 diabetes are time-restricted eating (commonly the 16:8 method), the 5:2 method, and fasting-mimicking diets.
- 16:8 (time-restricted eating): You eat all your meals within an 8-hour window, such as 10 a.m. to 6 p.m., and fast for the remaining 16 hours. Research links this approach to lower blood sugar and weight loss in the short term.
- 5:2 method: You eat normally five days a week and restrict to about 500 to 600 calories on two non-consecutive days. Trials using this format have shown HbA1c reductions of 0.7% to 1.2% over 20 weeks.
- Fasting-mimicking diet: You follow a very low calorie, plant-based plan for several consecutive days each month. One 12-month trial saw HbA1c drop from 6.9% to 6.7% using this approach.
When researchers ranked these methods specifically for improving insulin resistance, twice-weekly fasting came out slightly ahead, followed by time-restricted eating and then fasting-mimicking diets. The differences between them were modest, though, and the best method is ultimately the one you can sustain.
Medication Risks During Fasting
This is where intermittent fasting gets genuinely dangerous if you don’t plan ahead. Several common diabetes medications can cause blood sugar to drop too low when you skip meals, and some need to be adjusted days before you start fasting.
Sulfonylureas (a class of pills that stimulate insulin release) have effects lasting 24 to 36 hours. They need to be stopped at least a full day before fasting begins. Meglitinides, which are shorter-acting pills typically taken before each meal, should simply be skipped if you’re not eating. Taking one without a meal is a recipe for a dangerous blood sugar crash.
Insulin requires the most careful adjustment because its effects can linger for days. Some long-acting insulins work for 36 to 42 hours, meaning a dose taken on Monday is still active on Wednesday. Dose reductions may need to start two days before a fasting day. SGLT-2 inhibitors (a newer class of diabetes drug that works through the kidneys) are typically stopped two days before fasting begins because they increase the risk of dehydration.
On the safer end, metformin, pioglitazone, and DPP-4 inhibitors rarely cause low blood sugar on their own, so they generally don’t need adjustment during fasting windows. Still, combining any medication with significant calorie restriction changes the equation.
Who Should Be Cautious
The International Diabetes Federation specifically flags people with diabetes as being at higher risk from fasting due to the metabolic nature of the condition. Marked changes in food and liquid intake can trigger both dangerously low and dangerously high blood sugar, depending on your medication and overall health.
Some research also suggests that fasting can impair the body’s ability to burn fatty acids for energy due to drops in a compound called L-carnitine. This may explain side effects like fatigue and weakness that some people experience during fasting windows. Researchers have hypothesized that supplementing with related compounds could help, but this hasn’t been confirmed in clinical trials yet.
If you’re on insulin or sulfonylureas, have a history of severe low blood sugar episodes, or have other complications like kidney disease, fasting carries additional layers of risk. A fasting management plan created with your doctor, covering specific medication timing, blood sugar monitoring frequency, and clear thresholds for breaking a fast, is not optional in these cases.